{"Symbol": "ATRC", "AssetType": "Common Stock", "Name": "AtriCure Inc", "Description": "AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally. The company is headquartered in Mason, Ohio.", "CIK": "1323885", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "MEDICAL INSTRUMENTS & SUPPLIES", "Address": "7555 INNOVATION WAY, MASON, OH, UNITED STATES, 45040", "OfficialSite": "https://www.atricure.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "1623260000", "EBITDA": "-6211000", "PERatio": "None", "PEGRatio": "-1.18", "BookValue": "9.59", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-0.61", "RevenuePerShareTTM": "10.9", "ProfitMargin": "-0.0555", "OperatingMarginTTM": "0.0016", "ReturnOnAssetsTTM": "-0.0265", "ReturnOnEquityTTM": "-0.0611", "RevenueTTM": "518305000", "GrossProfitTTM": "388061000", "DilutedEPSTTM": "-0.61", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0.158", "AnalystTargetPrice": "51.44", "AnalystRatingStrongBuy": "4", "AnalystRatingBuy": "5", "AnalystRatingHold": "0", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "3.132", "PriceToBookRatio": "3.409", "EVToRevenue": "2.997", "EVToEBITDA": "-135.97", "Beta": "1.405", "52WeekHigh": "43.18", "52WeekLow": "28.29", "50DayMovingAverage": "38.96", "200DayMovingAverage": "35.28", "SharesOutstanding": "49717000", "SharesFloat": "47968900", "PercentInsiders": "3.194", "PercentInstitutions": "96.898", "DividendDate": "None", "ExDividendDate": "None"}